MindMotion GO
Neurorehabilitation (Stroke, Traumatic Brain Injury, etc.)
ApprovedCommercial
Key Facts
Indication
Neurorehabilitation (Stroke, Traumatic Brain Injury, etc.)
Phase
Approved
Status
Commercial
Company
About MindMaze Therapeutics
MindMaze Therapeutics has established itself as a leader in developing integrated neurotherapeutic combinations, merging behavior, software, devices, and data analytics into a cohesive treatment ecosystem. The company's commercially available platform, including MindMotion GO and the MindPod immersive gaming environment, is already impacting patient lives through deployments in clinical and home settings. With a focus on precision neurotherapeutics for rare diseases and a robust pipeline of digital motion assessment tools, MindMaze is redefining brain health recovery by leveraging proprietary technology to capture and analyze digital biomarkers.
View full company profile